These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 22190448

  • 1. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
    Venkatramani R, Wang L, Malvar J, Dias D, Sposto R, Malogolowkin MH, Mascarenhas L.
    Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
    [Abstract] [Full Text] [Related]

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Sep; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 3. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, Superina RA.
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [Abstract] [Full Text] [Related]

  • 4. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte JB, Brugieres L, Czauderna P, MacKinlay G, Vos A.
    Cancer; 2002 Feb 15; 94(4):1111-20. PubMed ID: 11920482
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
    Koh KN, Park M, Kim BE, Bae KW, Kim KM, Im HJ, Seo JJ.
    Pediatr Blood Cancer; 2011 Oct 15; 57(4):554-60. PubMed ID: 21370433
    [Abstract] [Full Text] [Related]

  • 7. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
    von Schweinitz D, Bürger D, Bode U, Weinel P, Erttmann R, Hecker H, Mildenberger H.
    Klin Padiatr; 1994 Oct 15; 206(4):282-8. PubMed ID: 7526028
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G.
    J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943
    [Abstract] [Full Text] [Related]

  • 9. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
    Ismail H, Broniszczak D, Kaliciński P, Dembowska-Bagińska B, Perek D, Teisseyre J, Kluge P, Kościesza A, Lembas A, Markiewicz M.
    J Pediatr Surg; 2012 Jul 20; 47(7):1331-9. PubMed ID: 22813792
    [Abstract] [Full Text] [Related]

  • 10. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.
    Meyers RL, Katzenstein HM, Krailo M, McGahren ED, Malogolowkin MH.
    J Pediatr Surg; 2007 Dec 20; 42(12):2050-6. PubMed ID: 18082706
    [Abstract] [Full Text] [Related]

  • 11. Features predicting unresectability in hepatoblastoma.
    D'Antiga L, Vallortigara F, Cillo U, Talenti E, Rugge M, Zancan L, Dall'Igna P, De Salvo GL, Perilongo G.
    Cancer; 2007 Sep 01; 110(5):1050-8. PubMed ID: 17661341
    [Abstract] [Full Text] [Related]

  • 12. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study.
    Wang LL, Filippi RZ, Zurakowski D, Archibald T, Vargas SO, Voss SD, Shamberger RC, Davies K, Kozakewich H, Perez-Atayde AR.
    Am J Surg Pathol; 2010 Mar 01; 34(3):287-99. PubMed ID: 20118773
    [Abstract] [Full Text] [Related]

  • 13. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H.
    Klin Padiatr; 1999 Mar 01; 211(4):305-9. PubMed ID: 10472567
    [Abstract] [Full Text] [Related]

  • 14. Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review.
    Ikeda H, Hachitanda Y, Tanimura M, Maruyama K, Koizumi T, Tsuchida Y.
    Cancer; 1998 May 01; 82(9):1789-96. PubMed ID: 9576303
    [Abstract] [Full Text] [Related]

  • 15. Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
    Heifetz SA, French M, Correa M, Grosfeld JL.
    Pediatr Pathol Lab Med; 1997 May 01; 17(6):857-74. PubMed ID: 9353826
    [Abstract] [Full Text] [Related]

  • 16. Single-agent cisplatin treatment of children with high-risk hepatoblastoma.
    Zhang YT, Feng LH, Zhong XD, Wang LZ, Chang J.
    J Pediatr Hematol Oncol; 2014 May 01; 36(4):271-5. PubMed ID: 24309602
    [Abstract] [Full Text] [Related]

  • 17. Is multifocality a prognostic factor in childhood hepatoblastoma?
    Saettini F, Conter V, Provenzi M, Rota M, Giraldi E, Foglia C, Cavalleri L, D'Antiga L.
    Pediatr Blood Cancer; 2014 Sep 01; 61(9):1593-7. PubMed ID: 24757164
    [Abstract] [Full Text] [Related]

  • 18. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
    Becker K, Furch C, Schmid I, von Schweinitz D, Häberle B.
    Pediatr Blood Cancer; 2015 Jan 01; 62(1):24-8. PubMed ID: 25251521
    [Abstract] [Full Text] [Related]

  • 19. Surgical strategies for unresectable hepatoblastomas.
    Tajiri T, Kimura O, Fumino S, Furukawa T, Iehara T, Souzaki R, Kinoshita Y, Koga Y, Suminoe A, Hara T, Kohashi K, Oda Y, Hishiki T, Hosoi H, Hiyama E, Taguchi T.
    J Pediatr Surg; 2012 Dec 01; 47(12):2194-8. PubMed ID: 23217875
    [Abstract] [Full Text] [Related]

  • 20. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
    Venkatramani R, Stein JE, Sapra A, Genyk Y, Jhaveri V, Malogolowkin M, Mascarenhas L.
    Br J Surg; 2015 Jan 01; 102(1):108-13. PubMed ID: 25349947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.